Opioid-Prescribing Practices for Post-Operative Patients in Otolaryngology: A Multiphasic Quality Improvement Project in a Single Large Institution by Gandee, Zachary et al.
Thomas Jefferson University
Jefferson Digital Commons
Phase 1 Class of 2021
12-2018
Opioid-Prescribing Practices for Post-Operative
Patients in Otolaryngology: A Multiphasic Quality
Improvement Project in a Single Large Institution
Zachary Gandee
Thomas Jefferson University, zachary.gandee@jefferson.edu
Sophia Dang
Thomas Jefferson University, sophia.dang@jefferson.edu
Alexander N. Duffy
Thomas Jefferson University, Alexander.Duffy@jefferson.edu
Jonathan C. Li
Thomas Jefferson University, Jonathan.Li@jefferson.edu
Tanvi Rana
Thomas Jefferson University, tanvi.rana@jefferson.edu
See next page for additional authorsLet us know how access to this document benefits you
Follow this and additional works at: https://jdc.jefferson.edu/si_phr_2021_phase1
Part of the Medical Education Commons, Otolaryngology Commons, Public Health Commons,
and the Surgery Commons
This Article is brought to you for free and open access by the Jefferson Digital Commons. The Jefferson Digital Commons is a service of Thomas
Jefferson University's Center for Teaching and Learning (CTL). The Commons is a showcase for Jefferson books and journals, peer-reviewed scholarly
publications, unique historical collections from the University archives, and teaching tools. The Jefferson Digital Commons allows researchers and
interested readers anywhere in the world to learn about and keep up to date with Jefferson scholarship. This article has been accepted for inclusion in
Phase 1 by an authorized administrator of the Jefferson Digital Commons. For more information, please contact:
JeffersonDigitalCommons@jefferson.edu.
Recommended Citation
Gandee, Zachary; Dang, Sophia; Duffy, Alexander N.; Li, Jonathan C.; Rana, Tanvi; Gunville, Brittany; Zhan, Tingting; Cottrill,
Elizabeth; and Cognetti, David, "Opioid-Prescribing Practices for Post-Operative Patients in Otolaryngology: A Multiphasic Quality
Improvement Project in a Single Large Institution" (2018). SKMC JeffMD Scholarly Inquiry, Phase 1, Project 1.
Authors
Zachary Gandee; Sophia Dang; Alexander N. Duffy; Jonathan C. Li; Tanvi Rana; Brittany Gunville; Tingting
Zhan; Elizabeth Cottrill, MD; and David Cognetti, MD
This abstract is available at Jefferson Digital Commons: https://jdc.jefferson.edu/si_phr_2021_phase1/16
Zachary Gandee 
Abstract Submission 
PHR Track 
 
Objectives: 
In otolaryngology, postoperative pain management lacks evidence-based guidelines. We 
investigated opioid prescription and consumption for common procedures to develop prescribing 
guidelines at our institution. 
 
Study Design: 
Prospective, survey study. 
 
Methods: 
Patients who underwent surgery between July and September were given surveys upon 
discharge and at first follow-up visit.  We assessed opioid usage and pain using the visual 
analog scale and opioid consumption throughout the postoperative period.  Opioid prescriptions 
were converted to a standardized unit of 5 mg Oxycodone pills for reporting.  Four procedures 
(transoral robotic surgery resection [TORS], sialendoscopy, parathyroidectomy/thyroidectomy, 
and parotidectomy) were selected for isolated analysis. 
 
Results: 
Of the 80 surveys that met criteria for inclusion for analysis, a total of 1,954.0 pills were prescribed, 
with 300.3 pills (15.4%) reported having been used by patients, leaving 1,653.7 pills (84.5%) 
unused.  TORS (n=12) average pills used: 4.9 ± 5.9 (95% CI: 1.6-8.3); total % pills unused: 89.3%.  
Sialendoscopy (n=13) average pills used: 4.2 ± 5.1 (95% CI: 1.1-7.4); total % pills unused: 72.5%. 
Parathyroidectomy/thyroidectomy (n=22) average pills used: 3.1 ± 4.4 (95% CI: 1.7-5.5); total % pills 
unused: 79.2%.  Parotidectomy (n=12) average pills used: 1.3 ± 2.5 (95% CI: 0.7-4.3); total % pills 
unused: 94.7%. 
 
Conclusions: 
At our institution, opioids for ((postoperative otolaryngology)) patients’ pain management in 
otolaryngologic procedures were prescribed in excess with 84.5% reported as unused.  Procedure-
specific opioid diversion pool ranged from 72.5%-94.7%.  Our findings provide a foundation for 
procedure-specific evidence-based opioid prescription guidelines. 
 
